You probably know NF as an artist, but in medical contexts NF stands for neurofibromatosis — a genetic condition that affects nerve tissue and can cause tumors, skin changes, and other complications. Neurofibromatosis varies widely in severity, so understanding its types, symptoms, and genetic basis helps you recognize what to watch for and what steps to take next.
This article What Is NF will explain how NF develops, how doctors diagnose and manage it, and what daily life can look like for someone with the condition. Expect clear, practical information about medical features, treatment options, and resources so you can make informed decisions or support someone who’s affected.
Understanding Neurofibromatosis
Neurofibromatosis (NF) describes a group of genetic conditions that cause tumors to form on nerves and affect skin, bones, and other tissues. You will encounter different types, inherited patterns, and a predictable set of signs that guide diagnosis and management.
Types of Neurofibromatosis
Three main types exist: NF1, NF2, and schwannomatosis.
NF1 is the most common and typically appears in childhood; you’ll often see multiple café-au-lait spots, freckling in skin folds, and cutaneous or plexiform neurofibromas. NF1 increases risk for learning difficulties, skeletal abnormalities, and vascular problems.
NF2 mainly affects hearing and balance. You can develop bilateral vestibular schwannomas (acoustic neuromas) that cause hearing loss, tinnitus, and balance issues. Other central nervous system tumors such as meningiomas and spinal schwannomas are common.
Schwannomatosis is rarer and usually presents in adulthood with chronic, often severe pain from multiple schwannomas. Unlike NF2, schwannomatosis generally spares the vestibular nerves, so hearing loss is less typical. Each type has distinct tumor patterns and clinical monitoring needs.
Genetic Causes and Inheritance
NF arises from mutations in specific tumor-suppressor genes.
- NF1 results from pathogenic variants in the NF1 gene on chromosome 17, which encodes neurofibromin.
- NF2 involves loss-of-function variants in the NF2 gene on chromosome 22, which encodes merlin (schwannomin).
- Schwannomatosis links to SMARCB1 or LZTR1 gene variants in some families.
Inheritance is autosomal dominant for NF1 and NF2; you have a 50% chance to pass the mutated gene to each child if you carry it. However, up to about half of NF cases arise from new (de novo) mutations with no affected parent. Variable expressivity means family members with the same mutation can show very different severity. Genetic testing and counseling clarify diagnosis, recurrence risk, and reproductive options.
Common Symptoms and Signs
Symptoms vary by type but share core features: tumor growth on nerves, skin changes, and neurologic effects.
For NF1, expect skin findings (six or more café-au-lait spots, axillary/inguinal freckling), cutaneous neurofibromas, plexiform neurofibromas that can cause disfigurement or pain, and learning or attention difficulties. Bone issues like scoliosis and pseudarthrosis may occur.
For NF2, the hallmark is progressive hearing loss from bilateral vestibular schwannomas, plus tinnitus and balance problems. You may also develop spinal tumors and brain tumors causing headaches, visual changes, or neurologic deficits.
In schwannomatosis, chronic neuropathic pain is the predominant symptom; motor or sensory deficits can appear depending on tumor location. Tumor-related pain and functional impairment drive most clinical visits. Regular imaging and symptom-directed care guide management.
Living With Neurofibromatosis
You will need regular medical monitoring, targeted treatments for specific symptoms, and access to community or specialist resources. Early diagnosis and coordinated care reduce complications and help you manage daily life.
Diagnosis and Medical Evaluation
Diagnosis usually starts with a clinical exam looking for café-au-lait spots, neurofibromas, Lisch nodules, and family history. Your provider may use established criteria for NF1, NF2, or schwannomatosis; genetic testing (sequencing or deletion/duplication analysis) can confirm the diagnosis in many cases.
Expect baseline tests after diagnosis: skin and neurological exams, ophthalmology assessment for optic pathway gliomas, blood pressure measurement, and imaging (MRI) when tumors or neurological signs are present. Children often need more frequent evaluations because complications can appear as they grow.
Keep a personal medical record with photos of skin findings, copies of imaging reports, and genetic test results. Bring this to every specialist appointment to avoid repeated tests and speed clinical decisions.
Treatment Options and Management
Treatment focuses on monitoring and addressing specific problems rather than curing the genetic condition. For symptomatic tumors, options include surgical removal, targeted drug therapy (e.g., MEK inhibitors for symptomatic plexiform neurofibromas), or radiologic surveillance when risk is low. Discuss risks and benefits of surgery, including nerve damage and scarring.
Manage non-tumor issues proactively: treat hypertension, provide learning and developmental support for school-aged children, and address chronic pain with physical therapy, medications, or interventional pain procedures. Regular dermatologic and ophthalmologic follow-up helps catch complications early.
Coordinate care through a multidisciplinary team—neurology, genetics, oncology, orthopedics, pain management, dermatology, and mental health. Ask about clinical trials if standard therapies are insufficient.
Long-Term Outlook and Support Resources
Most people with NF1 have a near-normal life expectancy but require lifelong surveillance for tumor growth, hypertension, and learning or psychosocial impacts. NF2 and schwannomatosis have different risks—hearing loss and balance problems are common in NF2 and often need audiology and vestibular care.
Use these practical resources:
- Genetic counseling for family planning and interpretation of test results.
- Specialty NF clinics for coordinated multispecialty care.
- Patient registries and clinical trial databases to find studies.
- Peer support groups and mental health professionals for coping strategies.
Keep up preventive care: routine blood pressure checks, age-appropriate cancer screenings, and prompt evaluation of new neurological symptoms. Document changes and share them with your care team to guide timely interventions.
